Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | CPA3 | P15088 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5599125 | 0.94 | KEAP1 (0.63) | KEAP1FFAR1TRPA1CYP1A2MDM2 | |
| SCHEMBL3857496 | 0.86 | MDM2 (0.71) | KEAP1FFAR1TRPA1CYP1A2MDM2 | |
| SCHEMBL7596738 | 0.85 | SLC7A5 (0.53) | KEAP1FFAR1CYP1A2ALDH1A1SLC7A5 | |
| SCHEMBL27947403 | 0.85 | ANPEP (0.52) | FFAR1CYP1A2ALDH1A1 | |
| SCHEMBL2565008 | 0.83 | CYP1A2 (0.52) | CYP1A2MDM2ALPIPKMPTGS1 | |
| SCHEMBL16738222 | 0.83 | KEAP1 (0.53) | KEAP1FFAR1TRPA1ALDH1A1ALPI | |
| SCHEMBL11087566 | 0.83 | ALDH1A1 (0.55) | KEAP1FFAR1TRPA1ALDH1A1HDAC2 | |
| SCHEMBL392827 | 0.81 | CYP1A2 (0.70) | KEAP1CYP1A2MDM2ALPIPKM | |
| SCHEMBL476969 | 0.81 | KEAP1 (0.61) | KEAP1FFAR1TRPA1CYP1A2ALDH1A1 | |
| SCHEMBL10889375 | 0.80 | ALDH1A1 (0.52) | KEAP1FFAR1ALDH1A1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3060574-A1 | ALPHA BETA MODULATING PEPTIDES | Alzhyme Pty Ltd (AU) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015058258-A1 | AΒ MODULATING PEPTIDES | ALZHYME PTY LTD (AU) | 2015-04-30 | — | — | WO | disclosed |
| CN-103492375-A | Pyrazole derivatives, preparation method thereof and composition for preventing and treating osteoporosis comprising the same | UNIV EWHA IND COLLABORATION | 2014-01-01 | — | — | CN | disclosed |
| EP-1263454-A2 | METHODS FOR ENHANCING THE BIOAVAILABILITY OF A DRUG | Praecis Pharmaceuticals Incorporated (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2000052048-A9 | MODULATORS OF BETA-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARM INC (US) | 2002-04-11 | — | — | WO | disclosed |
| EP-1161449-A1 | MODULATORS OF BETA-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | Praecis Pharmaceuticals Incorporated (US) | 2001-12-12 | — | — | EP | disclosed |
| WO-2001058470-A2 | METHODS FOR ENHANCING THE BIOAVAILABILITY OF A DRUG | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 2001-08-16 | — | — | WO | disclosed |
| WO-2000052048-A1 | MODULATORS OF BETA-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 2000-09-08 | — | — | WO | disclosed |
| EP-0929574-A1 | MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | Praecis Pharmaceuticals Incorporated (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998008868-A9 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | — | 1998-05-28 | — | — | WO | disclosed |
| WO-1998008868-A1 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 1998-03-05 | — | — | WO | disclosed |